| |
|
MASH | Abstract Library |
 |
| |
| The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors. |
|
|
| |
|
|
| |
| 3. | Environmental toxicants modulate disease severity in pediatric metabolic dysfunction-associated steatohepatitis |
| |
J Pediatr Gastroenterol Nutr. 2024 Sep 16. doi: 10.1002/jpn3.12346. Online ahead of print.
Ajay K Jain 1, Stefanie A Busgang 2, Chris Gennings 2, Katherine P Yates 3, Jeffrey B Schwimmer 4, Philip Rosenthal 5, Karen F Murray 6, Jean P Molleston 7, Ann Scheimann 8, Stavra A Xanthakos 9, Cynthia A Behling 10 11, Danielle Carpenter 12, Mark Fishbein 13, Brent A Neuschwander-Tetri 14, James Tonasia 3, Miriam B Vos 15
|
|
| |
| 4. | Decreases in cT1 and liver fat content reflect treatment-induced histological improvements in MASH |
| |
J Hepatol. 2024 Sep 19:S0168-8278(24)02559-5. doi: 10.1016/j.jhep.2024.08.031.Online ahead of print.
Naim Alkhouri 1, Cayden Beyer 2, Elizabeth Shumbayawonda 2, Anneli Andersson 2, Kitty Yale 3, Timothy Rolph 3, Raymond T Chung 4, Raj Vuppalanchi 5, Kenneth Cusi 6, Rohit Loomba 7, Michele Pansini 8, Andrea Dennis 9
|
|
| |
| 5. | TREM2 macrophages mediate the beneficial effects of bariatric surgery against MASH |
| |
Hepatology. 2024 Sep 18. doi: 10.1097/HEP.0000000000001098. Online ahead of print.
Gavin Fredrickson 1, Kira Florczak 1, Fanta Barrow 1, Shamsed Mahmud 2 3, Katrina Dietsche 1, Haiguang Wang 1, Preethy Parthiban 1, Andrew Hakeem 1, Rawan Almutlaq 1, Oyedele Adeyi 4, Adam Herman 5, Alessandro Bartolomucci 1, Christopher Staley 5, Xiao Dong 2 3, Cyrus Jahansouz 5, Jesse W Williams 1 6, Douglas G Mashek 3 7, Sayeed Ikramuddin 5, Xavier S Revelo 1 3 6
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 9. | DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases |
| |
Metabolism. 2024 Oct:159:155931. doi: 10.1016/j.metabol.2024.155931.Epub 2024 Jun 7.
Yehuda Handelsman 1, John E Anderson 2, George L Bakris 3, Christie M Ballantyne 4, Deepak L Bhatt 5, Zachary T Bloomgarden 6, Biykem Bozkurt 7, Matthew J Budoff 8, Javed Butler 9, David Z I Cherney 10, Ralph A DeFronzo 11, Stefano Del Prato 12, Robert H Eckel 13, Gerasimos Filippatos 14, Gregg C Fonarow 8, Vivian A Fonseca 15, W Timothy Garvey 16, Francesco Giorgino 17, Peter J Grant 18, Jennifer B Green 19, Stephen J Greene 20, Per-Henrik Groop 21, George Grunberger 22, Ania M Jastreboff 23, Paul S Jellinger 24, Kamlesh Khunti 25, Samuel Klein 26, Mikhail N Kosiborod 27, Pamela Kushner 28, Lawrence A Leiter 29, Norman E Lepor 8, Christos S Mantzoros 30, Chantal Mathieu 31, Christian W Mende 32, Erin D Michos 33, Javier Morales 34, Jorge Plutzky 35, Richard E Pratley 36, Kausik K Ray 37, Peter Rossing 38, Naveed Sattar 39, Peter E H Schwarz 40, Eberhard Standl 41, P Gabriel Steg 42, Lale Tokgözoglu 43, Jaakko Tuomilehto 44, Guillermo E Umpierrez 45, Paul Valensi 46, Matthew R Weir 47, John Wilding 48, Eugene E Wright Jr 49
|
|
| |
|
|
| |
|
|
| |
| 12. | GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease |
| |
JAMA Intern Med. 2024 Sep 16:e244661. doi: 10.1001/jamainternmed.2024.4661.Online ahead of print.
Fasiha Kanwal 1 2 3 4, Jennifer R Kramer 2 3, Liang Li 5, Yu-Xiao Yang 6 7, Yumei Cao 2 3, Xian Yu 2 3, Ronald Samuel 1 3, Basim Ali 1, Roxanne Desiderio 1 3, George Cholankeril 1, Mandeep Bajaj 8, Hashem B El-Serag 1 3 4, Steven M Asch 9 10
|
|
| |
| 13. | Agile scores in MASLD and ALD: External validation and their utility in clinical algorithms |
| |
Hepatol. 2024 Oct;81(4):590-599. doi: 10.1016/j.jhep.2024.05.021. Epub 2024 May 23.
Margarita Papatheodoridi 1, Victor De Ledinghen 2, Monica Lupsor-Platon 3, Fabrizio Bronte 4, Jerome Boursier 5, Omar Elshaarawy 6, Fabio Marra 7, Maja Thiele 8, Georgios Markakis 9, Audrey Payance 10, Edgar Brodkin 11, Laurent Castera 12, George Papatheodoridis 9, Aleksander Krag 8, Umberto Arena 7, Sebastian Mueller 13, Paul Cales 5, Vincenza Calvaruso 4, Adele Delamarre 2, Massimo Pinzani 11, Emmanuel A Tsochatzis 14
|
|
| |
| 14. | Longitudinal Links between Changes in Body Composition and Liver Disease Severity in Children and Adolescents with Metabolic Dysfunction-Associated Steatotic Liver Disease |
| |
J Pediatr. 2024 Sep 13:114301. doi: 10.1016/j.jpeds.2024.114301. Online ahead of print.
Alexandria Speakman 1, Kathryn Hitchcock 2, Emily Romantic 2, Venancio Quiambao 2, Abigail Lepolt 2, Sanita Ley 3, Ana Catalina Arce-Clachar 1, Kristin Bramlage 4, Lin Fei 5, Qin Sun 5, Stavra Xanthakos 1, Marialena Mouzaki 6
|
|
| |
|
|
| |
| 16. | Increases and decreases in liver stiffness measurement are independently associated with the risk of liver-related events in NAFLD |
| |
J Hepatol. 2024 Oct;81(4):600-608. doi: 10.1016/j.jhep.2024.05.008. Epub 2024 May 16.
Samer Gawrieh 1, Eduardo Vilar-Gomez 1, Laura A Wilson 2, Francis Pike 3, David E Kleiner 4, Brent A Neuschwander-Tetri 5, Anna Mae Diehl 6, Srinivasan Dasarathy 7, Kris V Kowdley 8, Bilal Hameed 9, James Tonascia 2, Rohit Loomba 10, Arun J Sanyal 11, Naga Chalasani 12; NASH Clinical Research Network
|
|
| |
|
|
| |
| 18. | Substance use moderates relationships between apolipoprotein E genotype, hepatitis C, cognition, and depression in Miami Adult Studies on HIV (MASH) participants |
| |
Neurovirol. 2024 Aug 12. doi: 10.1007/s13365-024-01225-8. Online ahead of print.
Shanna L Burke 1, Adrienne Grudzien 2 3, Tan Li 4, Stephanie Garcia 4, Sabrina Sales Martinez 5, Emily Jurich 2, Daniel R Jimenez 2, Jacqueline Hernández 5, Qingyun Liu 5, Tahirah A Tyrell 6, Adriana L Campa 5, Anglique Johnson 5, Zoran Bursac 4, Marianna K Baum 5
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 22. | Glycated haemoglobin is a major predictor of disease severity in patients with NAFLD |
| |
Diabetes Res Clin Pract. 2024 Aug 13:111820. doi: 10.1016/j.diabres.2024.111820.Online ahead of print.
Santo Colosimo 1, Hamish Miller 2, Dimitrios A Koutoukidis 3, Thomas Marjot 4, Garry D Tan 1, David J Harman 5, Guruprasad P Aithal 6, Pinelopi Manousou 7, Roberta Forlano 7, Richard Parker 8, David A Sheridan 9, Philip N Newsome 10, William Alazawi 11, Jeremy F Cobbold 12, Jeremy W Tomlinson 13
|
|
| |
|
|
| |
|
|
| |
| 25. | Greater hepatic lipid saturation is associated with impaired glycaemic regulation in men with metabolic dysfunction-associated steatotic liver disease but is not altered by 6 weeks of exercise training |
| |
Diabetes Obes Metab. 2024 Sep;26(9):4030-4042.doi: 10.1111/dom.15755. Epub 2024 Jul 8.
Scott A Willis 1 2, Sundus Malaikah 1 2 3, Stephen J Bawden 4 5, Aron P Sherry 1 2 6, Jack A Sargeant 2 7, Nicole A Coull 2 8, Christopher R Bradley 4 5, Alex Rowlands 2 8, Iyad Naim 4 5, Gaël Ennequin 9, Thomas Yates 2 8, Ghazala Waheed 2 8, Penny Gowland 4 5, David J Stensel 1 2 10, David R Webb 2 8, Melanie J Davies 2 8, Guruprasad P Aithal 5 11, James A King 1 2
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 29. | Reproducibility and Repeatability of US Shear-Wave and Transient Elastography in Nonalcoholic Fatty Liver Disease |
| |
Radiology. 2024 Sep;312(3):e233094. doi: 10.1148/radiol.233094.
Theodore T Pierce # 1, Arinc Ozturk # 1, Sarah P Sherlock 1, Guilherme Moura Cunha 1, Xiaohong Wang 1, Qian Li 1, David Hunt 1, Michael S Middleton 1, Marian Martin 1, Kathleen E Corey 1, Hannah Edenbaum 1, Sudha S Shankar 1, Helen Heymann 1, Tania N Kamphaus 1, Roberto A Calle 1, Yesenia Covarrubias 1, Rohit Loomba 1, Nancy A Obuchowski 1, Arun J Sanyal 1, Claude B Sirlin 1, Kathryn J Fowler # 1, Anthony E Samir # 1
|
|
| |
|
|
| |
|
|
| |
| 32. | Clinical outcomes of MAFLD versus NAFLD: A meta-analysis of observational studies |
| |
Liver Int. 2024 Aug 19. doi: 10.1111/liv.16075. Online ahead of print.
Grazia Pennisi 1, Giuseppe Infantino 1, Ciro Celsa 1, Gabriele Di Maria 1, Marco Enea 2, Marco Vaccaro 2, Roberto Cannella 3, Carlo Ciccioli 1, Claudia La Mantia 1, Alessandro Mantovani 4, Francesco Mercurio 1, Herbert Tilg 5, Giovanni Targher 6 7, Vito Di Marco 1, Calogero Cammà 1, Salvatore Petta 1
|
|
| |
|
|
| |
|
|
| |
| 35. | MASLD in people with HIV exhibits higher fibrosis stage despite lower disease activity than in matched controls |
| |
Aliment Pharmacol Ther. 2024 Sep 5. doi: 10.1111/apt.18236. Online ahead of print.
Daniela S Allende 1, Oscar Cummings 2, Alice L Sternberg 3, Cynthia A Behling 4, Danielle Carpenter 5, Ryan M Gill 6, Cynthia D Guy 7, Matthew M Yeh 8, Samer Gawrieh 9, Richard K Sterling 10, Susanna Naggie 11, Rohit Loomba 12, Jennifer C Price 6, Mary McLaughlin 13, Colleen Hadigan 13, Holly Crandall 2, Patricia Belt 3, Laura Wilson 3, Naga P Chalasani 9, David E Kleiner 14; HIV NASH and NASH Clinical Research Groups
|
|
| |
| 36. | Prognosis of Transplant-Ineligible Patients with Cirrhosis and Acute Kidney Injury Who Initiate Renal Replacement Therapy |
| |
Dig Dis Sci. 2024 Aug 31. doi: 10.1007/s10620-024-08623-2. Online ahead of print.
Paige McLean Diaz 1, Danielle L Saly 2, Nora Horick 3, Romela Petrosyan 4, Zachary Gitto 5, Teresa Indriolo 6, Lucinda Li 6, Olivia Kahn-Boesel 7, John Donlan 7, Blair Robinson 8, Lindsay Dow 8, Annie Liu 2, Areej El-Jawahri 9, Xavier Vela Parada 10, Sara Combs 11, Joao Teixeira 12, Raymond Chung 6, Andrew S Allegretti 2, Nneka N Ufere 13
|
|
| |
|
|
| |
|
|
| |
| 39. | Lower hepatocellular carcinoma surveillance in metabolic dysfunction-associated steatotic liver disease: Impact on treatment eligibility |
| |
J Gastroenterol Hepatol. 2024 Aug 27. doi: 10.1111/jgh.16727. Online ahead of print.
Connor Henry-Blake 1, Vinay Balachandrakumar 1, Mohamed Kassab 1, Joshua Devonport 1, Charmaine Matthews 1, James Fox 1, Elisabeth Baggus 1, Alexander Henney 2 3 4, Nicholas Stern 1, Daniel J Cuthbertson 2 3 4, Daniel Palmer 5, Philip J Johnson 5, David M Hughes 6, Theresa J Hydes 1 3 4, Timothy J S Cross 1 5
|
|
| |
| 40. | EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) |
| |
J Hepatol. 2024 Sep;81(3):492-542. doi: 10.1016/j.jhep.2024.04.031.Epub 2024 Jun 7.
European Association for the Study of the Liver (EASL). Electronic address: easloffice@easloffice.eu; European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO); European Association for the Study of the Liver (EASL)
Collaborators
- Frank Tacke, Paul Horn, Vincent Wai-Sun Wong, Vlad Ratziu, Elisabetta Bugianesi, Sven Francque, Shira Zelber-Sagi, Luca Valenti, Michael Roden, Fritz Schick, Hannele Yki-Järvinen, Amalia Gastaldelli, Roberto Vettor, Gema Frühbeck, Dror Dicker
|
|
| |
|
|
| |
|
|
| |
| 43. | Liver stiffness progression in biopsy-proven metabolic dysfunction-associated steatotic disease among people with diabetes versus people without diabetes: A prospective multicenter study |
| |
Hepatology. 2024 Jul 19. doi: 10.1097/HEP.0000000000001015. Online ahead of print.
Daniel Q Huang 1 2 3, Laura A Wilson 4, Cynthia Behling 5, Maral Amangurbanova 1, David E Kleiner 6, Kris V Kowdley 7, Srinivasan Dasarathy 8, Norah A Terrault 9, Anna Mae Diehl 10, Naga Chalasani 11, Brent A Neuschwander-Tetri 12, Arun J Sanyal 13, James Tonascia 4, Rohit Loomba 1 14; NASH Clinical Research Network
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 52. | Substance use moderates relationships between apolipoprotein E genotype, hepatitis C, cognition, and depression in Miami Adult Studies on HIV (MASH) participants |
| |
Neurovirol. 2024 Aug 12. doi: 10.1007/s13365-024-01225-8. Online ahead of print.
Shanna L Burke 1, Adrienne Grudzien 2 3, Tan Li 4, Stephanie Garcia 4, Sabrina Sales Martinez 5, Emily Jurich 2, Daniel R Jimenez 2, Jacqueline Hernández 5, Qingyun Liu 5, Tahirah A Tyrell 6, Adriana L Campa 5, Anglique Johnson 5, Zoran Bursac 4, Marianna K Baum 5
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 57. | Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis |
| |
N Engl J Med. 2024 Jul 25;391(4):299-310. doi: 10.1056/NEJMoa2401943.Epub 2024 Jun 8.
Rohit Loomba 1, Mark L Hartman 1, Eric J Lawitz 1, Raj Vuppalanchi 1, Jérôme Boursier 1, Elisabetta Bugianesi 1, Masato Yoneda 1, Cynthia Behling 1, Oscar W Cummings 1, Yuanyuan Tang 1, Bram Brouwers 1, Deborah A Robins 1, Amir Nikooie 1, Mathijs C Bunck 1, Axel Haupt 1, Arun J Sanyal 1; SYNERGY-NASH Investigators
Collaborators
- SYNERGY-NASH Investigators:
Christophe De Block, Charlotte De Vloo, Hendrik Reynaert, Ann Mertens, Anja Geerts, Christophe Bureau, Lionel Wander, Vlad Ratziu, Jérôme Boursier, Victor De Ledinhgen, Cyrielle Caussy, Marie Lequoy, Armelle Poujol Robert, Eli Zuckerman, Ella Veitsman, Rifaat Safadi, Ziv Ben-Ari, Gadi Lalazar, Nimer Assy, Emanuela Orsi, Gaetano Serviddio, Elisabetta Bugianesi, Salvatore Petta, Palermo Palermo, Luca Miele, Frida Leonetti, Kazuo Notsumata, Yasuhiro Asahina, Yuji Ogawa, Yokohama Yoshiyuki Ueno, Shigetoshi Fujiyama, Toshihide Shima, Masato Yoneda, Hirokazu Takahashi, Saga Hiroshi Tobita, Hideki Hayashi, Takeshi Yokoo, Masahiro Kido, Masashi Yoneda, Ken Furuya, Saiyu Tanaka, Yoshito Itoh, Hideki Fujii, Alma Laura Ladron de Guevara, Jorge Rojas Serrano, Enrique Fernandez Castro, Eduardo Mendoza Fuerte, Marcin Ojrzanowski, Ewa Czernecka, Santiago Tofe Povedano, Luis de Teresa Parreño, Javier Garcia de Paso Mora, Manuel Romero Gomez, Javier Crespo Garcia, Jose Luis Calleja Panero, Agustin Albillos, Shalini Iyengar, Carol Pretswell, Madhu Gowda, Karen Faulkner, Kosh Agarwal, William Alazawi, Cyril Sieberhagen, Pinelopi Manousou, Stephen Ryder, Jeremy Cobbold, Matthew Armstrong, Daniel Forton, Seth Baum, Juan Pablo Frias, David Guzman, Stanley Hsia, Julio Rosenstock, Kathryn Jean Lucas, Andrew Talal, Ajay Chaudhuri, Susan Brian, Tira Chaicha-Brom, Anuj Bhargava, Gholamreza Bonabi, Mark Borchelt, Michele Reynolds, Sherif Naguib, Rizwana Mohseni, Hernan Salazar, Thomas Klein, Richard Glover, John Scott, Eva-Maria Heurich, Hesham Elgouhari, Syed Lateef, Zeid Kayali, Gary Reiss, Rohit Loomba, Brian Borg, Muhammad Sheikh, Raj Vuppalanchi, Howard Schwartz, Meagan Gray, Charles Landis, Ira Jacobson, Henry Levine, Meena Bansal, Amreen Dinani, Amon Asgharpour, Eric Lawitz, Samuel Sigal, Abdullah Mubarak, Mark Leibowitz, Randall Severance, Jewel White, William Jennings, Judith White, Robert Meyer, Robert Perry, Robert Jenders, Mark McKenzie, Obadias Marquez, Christopher Still, Ernesto Fuentes, Kevin Merkes, Laura Pearlman
|
|
| |
|
|
| |
| 59. | Artificial intelligence scoring of liver biopsies in a phase II trial of semaglutide in nonalcoholic steatohepatitis |
| |
Hepatology. 2024 Jul 1;80(1):173-185. doi: 10.1097/HEP.0000000000000723.Epub 2023 Dec 19.
Vlad Ratziu 1, Sven Francque 2 3 4, Cynthia A Behling 5, Vanja Cejvanovic 6, Helena Cortez-Pinto 7, Janani S Iyer 8, Niels Krarup 6, Quang Le 8, Anne-Sophie Sejling 6, Dina Tiniakos 9 10, Stephen A Harrison 11
|
|
| |
|
|
| |
|
|
| |
| 62. | Performance of novel collagen turnover biomarkers to detect increased liver stiffness in MASLD |
| |
J Intern Med. 2024 Aug;296(2):177-186. doi: 10.1111/joim.13813. Epub 2024 Jul 3.
Hannes Hegmar 1 2, Thomas Wiggers 3, Patrik Nasr 4, Johan Vessby 5, Stergios Kechagias 4, Nils Nyhlin 6, Hanns-Ulrich Marschall 7, Åsa Danielsson Borssén 8, Rickard Strandberg 2, Morten Karsdal 3, Diana Julie Leeming 3, Mattias Ekstedt 4, Hannes Hagström 1 2
|
|
| |
| 63. | Functional characterization of 2,832 JAG1 variants supports reclassification for Alagille syndrome and improves guidance for clinical variant interpretation |
| |
Am J Hum Genet. 2024 Jul 15:S0002-9297(24)00218-0. doi: 10.1016/j.ajhg.2024.06.011.Online ahead of print.
Melissa A Gilbert 1, Ernest Keefer-Jacques 2, Tanaya Jadhav 2, Daniel Antfolk 3, Qianqian Ming 3, Nicolette Valente 2, Grace Tzun-Wen Shaw 2, Christopher J Sottolano 4, Grace Matwijec 2, Vincent C Luca 3, Kathleen M Loomes 5, Ramakrishnan Rajagopalan 4, Tristan J Hayeck 4, Nancy B Spinner 4
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 67. | Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis |
| |
N Engl J Med. 2024 Jul 25;391(4):299-310. doi: 10.1056/NEJMoa2401943.Epub 2024 Jun 8.
Rohit Loomba 1, Mark L Hartman 1, Eric J Lawitz 1, Raj Vuppalanchi 1, Jérôme Boursier 1, Elisabetta Bugianesi 1, Masato Yoneda 1, Cynthia Behling 1, Oscar W Cummings 1, Yuanyuan Tang 1, Bram Brouwers 1, Deborah A Robins 1, Amir Nikooie 1, Mathijs C Bunck 1, Axel Haupt 1, Arun J Sanyal 1; SYNERGY-NASH Investigators
Collaborators
SYNERGY-NASH Investigators:
Christophe De Block, Charlotte De Vloo, Hendrik Reynaert, Ann Mertens, Anja Geerts, Christophe Bureau, Lionel Wander, Vlad Ratziu, Jérôme Boursier, Victor De Ledinhgen, Cyrielle Caussy, Marie Lequoy, Armelle Poujol Robert, Eli Zuckerman, Ella Veitsman, Rifaat Safadi, Ziv Ben-Ari, Gadi Lalazar, Nimer Assy, Emanuela Orsi, Gaetano Serviddio, Elisabetta Bugianesi, Salvatore Petta, Palermo Palermo, Luca Miele, Frida Leonetti, Kazuo Notsumata, Yasuhiro Asahina, Yuji Ogawa, Yokohama Yoshiyuki Ueno, Shigetoshi Fujiyama, Toshihide Shima, Masato Yoneda, Hirokazu Takahashi, Saga Hiroshi Tobita, Hideki Hayashi, Takeshi Yokoo, Masahiro Kido, Masashi Yoneda, Ken Furuya, Saiyu Tanaka, Yoshito Itoh, Hideki Fujii, Alma Laura Ladron de Guevara, Jorge Rojas Serrano, Enrique Fernandez Castro, Eduardo Mendoza Fuerte, Marcin Ojrzanowski, Ewa Czernecka, Santiago Tofe Povedano, Luis de Teresa Parreño, Javier Garcia de Paso Mora, Manuel Romero Gomez, Javier Crespo Garcia, Jose Luis Calleja Panero, Agustin Albillos, Shalini Iyengar, Carol Pretswell, Madhu Gowda, Karen Faulkner, Kosh Agarwal, William Alazawi, Cyril Sieberhagen, Pinelopi Manousou, Stephen Ryder, Jeremy Cobbold, Matthew Armstrong, Daniel Forton, Seth Baum, Juan Pablo Frias, David Guzman, Stanley Hsia, Julio Rosenstock, Kathryn Jean Lucas, Andrew Talal, Ajay Chaudhuri, Susan Brian, Tira Chaicha-Brom, Anuj Bhargava, Gholamreza Bonabi, Mark Borchelt, Michele Reynolds, Sherif Naguib, Rizwana Mohseni, Hernan Salazar, Thomas Klein, Richard Glover, John Scott, Eva-Maria Heurich, Hesham Elgouhari, Syed Lateef, Zeid Kayali, Gary Reiss, Rohit Loomba, Brian Borg, Muhammad Sheikh, Raj Vuppalanchi, Howard Schwartz, Meagan Gray, Charles Landis, Ira Jacobson, Henry Levine, Meena Bansal, Amreen Dinani, Amon Asgharpour, Eric Lawitz, Samuel Sigal, Abdullah Mubarak, Mark Leibowitz, Randall Severance, Jewel White, William Jennings, Judith White, Robert Meyer, Robert Perry, Robert Jenders, Mark McKenzie, Obadias Marquez, Christopher Still, Ernesto Fuentes, Kevin Merkes, Laura Pearlman
|
|
| |
|
|
| |
|
|
| |
| 70. | Liver stiffness progression in biopsy-proven metabolic dysfunction-associated steatotic disease among people with diabetes versus people without diabetes: A prospective multicenter study |
| |
Hepatology. 2024 Jul 19. doi: 10.1097/HEP.0000000000001015. Online ahead of print.
Daniel Q Huang 1 2 3, Laura A Wilson 4, Cynthia Behling 5, Maral Amangurbanova 1, David E Kleiner 6, Kris V Kowdley 7, Srinivasan Dasarathy 8, Norah A Terrault 9, Anna Mae Diehl 10, Naga Chalasani 11, Brent A Neuschwander-Tetri 12, Arun J Sanyal 13, James Tonascia 4, Rohit Loomba 1 14; NASH Clinical Research Network
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 83. | A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease |
| |
Hepatol Int. 2024 Jun 15. doi: 10.1007/s12072-024-10702-5. Online ahead of print.
Huai Zhang 1, Giovanni Targher 2, Christopher D Byrne 3, Seung Up Kim 4, Vincent Wai-Sun Wong 5, Luca Valenti 6 7, Myer Glickman 8, Jaime Ponce 9, Christos S Mantzoros 10, Javier Crespo 11, Henning Gronbaek 12, Wah Yang 13, Mohammed Eslam 14, Robert J Wong 15, Mariana Verdelho Machado 16, Ming-Lung Yu 17 18, Omar M Ghanem 19, Takeshi Okanoue 20, Jun-Feng Liu 21, Yong-Ho Lee 22, Xiao-Yuan Xu 23, Qiuwei Pan 24, Meili Sui 25, Amedeo Lonardo 26, Yusuf Yilmaz 27, Li-Yong Zhu 28, Christophe Moreno 29, Luca Miele 30, Monica Lupsor-Platon 31, Lei Zhao 32, Teresa LeAnn LaMasters 33, Robert G Gish 34, Huijie Zhang 35, Marius Nedelcu 36, Wah Kheong Chan 37, Ming-Feng Xia 38, Fernando Bril 39, Jun-Ping Shi 40, Christian Datz 41, Stefano Romeo 42 43 44, Jian Sun 45, Dan Liu 46, Silvia Sookoian 47 48 49, Yi-Min Mao 50, Nahum Méndez-Sánchez 51, Xiao-Yan Wang 52, Nikolaos T Pyrsopoulos 53, Jian-Gao Fan 54, Yasser Fouad 55, Dan-Qin Sun 56 57, Cosimo Giannini 58, Jin Chai 59, Ze-Feng Xia 60, Dae Won Jun 61, Guo-Jing Li 62, Sombat Treeprasertsuk 63, Ying-Xu Li |
|
| |
|
|
| |
|
|
| |
| 86. | Artificial intelligence scoring of liver biopsies in a phase II trial of semaglutide in nonalcoholic steatohepatitis |
| |
Hepatology. 2024 Jul 1;80(1):173-185. doi: 10.1097/HEP.0000000000000723.Epub 2023 Dec 19.
Vlad Ratziu 1, Sven Francque 2 3 4, Cynthia A Behling 5, Vanja Cejvanovic 6, Helena Cortez-Pinto 7, Janani S Iyer 8, Niels Krarup 6, Quang Le 8, Anne-Sophie Sejling 6, Dina Tiniakos 9 10, Stephen A Harrison 11
|
|
| |
|
|
| |
|
|
| |
| 89. | The cost implications of Wilson disease among hospitalized patients: analysis of USA hospitals |
| |
Eur JGastroenterolHepatol. 2024Jul1;36(7):929940. doi:10.1097/MEG.0000000000002777.Epub 2024 Apr 23.
David Uihwan Lee 1, Ashton Harmacinski 1, Aneesh Bahadur 2, Ki Jung Lee 2, Hannah Chou 2, Mohammed Rifat Shaik 1, Harrison Chou 2, Gregory Hongyuan Fan 2, Jean Kwon 2, Reid Ponder 2, Kevin Chang 2, KeeSeok Lee 2, Zurabi Lominadze 1
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 94. | A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease |
| |
Hepatol Int. 2024 Jun 15. doi: 10.1007/s12072-024-10702-5. Online ahead of print.
Huai Zhang 1, Giovanni Targher 2, Christopher D Byrne 3, Seung Up Kim 4, Vincent Wai-Sun Wong 5, Luca Valenti 6 7, Myer Glickman 8, Jaime Ponce 9, Christos S Mantzoros 10, Javier Crespo 11, Henning Gronbaek 12, Wah Yang 13, Mohammed Eslam 14, Robert J Wong 15, Mariana Verdelho Machado 16, Ming-Lung Yu 17 18, Omar M Ghanem 19, Takeshi Okanoue 20, Jun-Feng Liu 21, Yong-Ho Lee 22, Xiao-Yuan Xu 23, Qiuwei Pan 24, Meili Sui 25, Amedeo Lonardo 26, Yusuf Yilmaz 27, Li-Yong Zhu 28, Christophe Moreno 29, Luca Miele 30, Monica Lupsor-Platon 31, Lei Zhao 32, Teresa LeAnn LaMasters 33, Robert G Gish 34, Huijie Zhang 35, Marius Nedelcu 36, Wah Kheong Chan 37, Ming-Feng Xia 38, Fernando Bril 39, Jun-Ping Shi 40, Christian Datz 41, Stefano Romeo 42 43 44, Jian Sun 45, Dan Liu 46, Silvia Sookoian 47 48 49, Yi-Min Mao 50, Nahum Méndez-Sánchez 51, Xiao-Yan Wang 52, Nikolaos T Pyrsopoulos 53, Jian-Gao Fan 54, Yasser Fouad 55, Dan-Qin Sun 56 57, Cosimo Giannini 58, Jin Chai 59, Ze-Feng Xia 60, Dae Won Jun 61, Guo-Jing Li 62, Sombat Treeprasertsuk 63, Ying-Xu Li |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 100. | Hepatic steatosis, metabolic dysfunction and risk of mortality: findings from a multinational prospective cohort study |
| |
BMC Med. 2024 Jun 3;22(1):221. doi: 10.1186/s12916-024-03366-3.
Ana-Lucia Mayén 1, Mirna Sabra 1, Elom K Aglago 2, Gabriel Perlemuter 3 4 5, Cosmin Voican 3 4 5, Ines Ramos 1, Charlotte Debras 1, Jessica Blanco 1, Vivian Viallon 1, Pietro Ferrari 1, Anja Olsen 6 7, Anne Tjønneland 6 7, Fie Langmann 7, Christina C Dahm 7, Joseph Rothwell 8, Nasser Laouali 8, Chloé Marques 8, Matthias B Schulze 9, Verena Katzke 10, Rudolf Kaaks 10, Domenico Palli 11, Alessandra Macciotta 12, Salvatore Panico 13, Rosario Tumino 14, Claudia Agnoli 15, Marta Farràs 16, Esther Molina-Montes 17 18 19 20, Pilar Amiano 18 21 22, María-Dolores Chirlaque 18 23, Jesús Castilla 18 24, Mårten Werner 25, Stina Bodén 26, Alicia K Heath 2, Kostas Tsilidis 2, Dagfinn Aune 2 27 28, Elisabete Weiderpass 29, Heinz Freisling 1, Marc J Gunter 2, Mazda Jenab 30
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 110. | Age, BMI, and Type 2 Diabetes Modify the Relationship Between PNPLA3 and Advanced Fibrosis in Children and Adults With NAFLD |
| |
Clin Gastroenterol Hepatol. 2024 May;22(5):1024-1036.e2. doi:10.1016/j.cgh.2023.12.009.Epub 2023 Dec 23.
Chaowapong Jarasvaraparn 1, Eduardo Vilar-Gomez 2, Katherine P Yates 3, Laura A Wilson 3, Brent Neuschwander-Tetri 4, Rohit Loomba 5, Oscar Cummings 6, Miriam Vos 7, Stavra Xanthakos 8, Jeffrey Schwimmer 9, Jean P Molleston 1, Arun Sanyal 10, James Tonascia 11, Naga Chalasani 12
|
|
| |
|
|
| |
|
|
| |
| 113. | Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A Scandinavian cohort study |
| |
Hepatology. 2024 Jun 1;79(6):1401-1411. doi: 10.1097/HEP.0000000000000712.Epub 2023 Dec 12.
Arvid Engström 1, Viktor Wintzell 1, Mads Melbye 2 3 4 5, Henrik Svanström 1 6, Björn Eliasson 7, Soffia Gudbjörnsdottir 7 8, Kristian Hveem 4 9, Christian Jonasson 4 9, Anders Hviid 6 10, Peter Ueda 1, Björn Pasternak 1 6
|
|
| |
|
|
| |
|
|
| |
| 116. | Poor accuracy and sustainability of the first-step FIB4 EASL pathway for stratifying steatotic liver disease risk in the general population |
| |
Aliment Pharmacol Ther. 2024 Jun;59(11):1402-1412. doi: 10.1111/apt.17953. Epub 2024 Mar 18.
Antonio De Vincentis 1, Federica Tavaglione 2 3, Shinichi Namba 4, Masahiro Kanai 4 5 6, Yukinori Okada 4 7 8 9 10 11, Yoichiro Kamatani 12, Samantha Maurotti 13, Claudio Pedone 14, Raffaele Antonelli Incalzi 1, Luca Valenti 15 16, Stefano Romeo 3 13 17, Umberto Vespasiani-Gentilucci 2
|
|
| |
| 117. | Progress is impossible without change: understanding the evolving nomenclature of steatotic liver disease and its effect on hepatology practice |
| |
Lancet Gastroenterol Hepatol. 2024 Jun;9(6):577-582.doi: 10.1016/S2468-1253(23)00453-3. Epub 2024 Feb 28.
Paul N Brennan 1, Oliver D Tavabie 2, Wenhao Li 3, Thomas Marjot 4, Lynsey Corless 5, Jonathan A Fallowfield 6, Helen Jarvis 7, Dina Mansour 8, Stuart McPherson 9, William Rosenberg 10, Karen Rockell 11, Jeremy Tomlinson 4, Andrew Yeoman 12, Emmanuel A Tsochatzis 10, John F Dillon 1, William Alazawi 3, Kushala W M Abeysekera 13
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 126. | Clinical and patient-reported outcomes in patients with chronic hepatitis B and C and non-alcoholic fatty liver disease from real-world practices in Saudi Arabia, Turkey and Egypt |
| |
J Viral Hepat. 2024 Apr 15. doi: 10.1111/jvh.13935. Online ahead of print.
Saleh A Alqahtani 1 2 3, Yusuf Yilmaz 1 4, Mohamed El-Kassas 1 5, Khalid Alswat 1 6, Faisal Sanai 7, May AlZahrani 8, Faisal Abaalkhail 9 10, Manal AlShaikh 8, Waleed K Al-Hamoudi 2 6, Fatema Nader 1 11 12, Maria Stepanova 1 11 12, Zobair M Younossi 1 11 12; Global NASH Council
|
|
| |
|
|
| |
|
|
| |
| 129. | Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease |
| |
JAMA. 2024 Mar 21. doi: 10.1001/jama.2024.1447. Online ahead of print.
Huapeng Lin 1 2, Hye Won Lee 3, Terry Cheuk-Fung Yip 1 2, Emmanuel Tsochatzis 4, Salvatore Petta 5, Elisabetta Bugianesi 6, Masato Yoneda 7, Ming-Hua Zheng 8, Hannes Hagström 9 10, Jérôme Boursier 11 12, José Luis Calleja 13, George Boon-Bee Goh 14, Wah-Kheong Chan 15, Rocio Gallego-Durán 16, Arun J Sanyal 17, Victor de Lédinghen 18, Philip N Newsome 19, Jian-Gao Fan 20, Laurent Castéra 21, Michelle Lai 22, Stephen A Harrison 23 24, Céline Fournier-Poizat 25, Grace Lai-Hung Wong 1 2, Grazia Pennisi 5, Angelo Armandi 6, Atsushi Nakajima 7, Wen-Yue Liu 26, Ying Shang 9, Marc de Saint-Loup 11, Elba Llop 13, Kevin Kim-Jun Teh 14, Carmen Lara-Romero 16, Amon Asgharpour 17, Sara Mahgoub 19, Mandy Sau-Wai Chan 25, Clemence M Canivet 11 12, Manuel Romero-Gomez 16, Seung Up Kim 3, Vincent Wai-Sun Wong 1 2; VCTE-Prognosis Study Group
|
|
| |
|
|
| |
| 131. | Impact of age on NIS2+™ and other non-invasive blood tests for the evaluation of liver disease and detection of at-risk MASH |
| |
JHEP Rep. 2024 Jan 19;6(4):101011. doi: 10.1016/j.jhepr.2024.101011. eCollection 2024 Apr.
Quentin M Anstee 1 2, Jeremy Magnanensi 3, Yacine Hajji 3, Alexandra Caron 3, Zouher Majd 3, Christian Rosenquist 3, Dean W Hum 3, Bart Staels 4, Margery A Connelly 5, Rohit Loomba 6, Stephen A Harrison 7 8, Vlad Ratziu 9, Arun J Sanyal 10
|
|
| |
| 132. | Aspirin for Metabolic Dysfunction-Associated Steatotic Liver Disease Without Cirrhosis: A Randomized Clinical Trial |
| |
JAMA. 2024 Mar 19;331(11):920-929. doi: 10.1001/jama.2024.1215.
Tracey G Simon 1 2 3, Robert M Wilechansky 1 2 4, Stefania Stoyanova 4, Alessandra Grossman 4, Laura E Dichtel 2 5, Georg M Lauer 2 4, Karen K Miller 2 5, Yujin Hoshida 6, Kathleen E Corey 1 2 4, Rohit Loomba 7, Raymond T Chung 1 2 4, Andrew T Chan 1 2 4
|
|
| |
|
|
| |
| 134. | Safety and Efficacy of Efruxifermin in Combination With a GLP-1 Receptor Agonist in Patients With NASH/MASH and Type 2 Diabetes in a Randomized Phase 2 Study |
| |
ClinGastroenterolHepatol. 2024Mar4:S15423565(24)00226X.doi:10.1016/j.cgh.2024.02.022. Online ahead of print.
Stephen A Harrison 1, Juan P Frias 2, K Jean Lucas 3, Gary Reiss 4, Guy Neff 5, Sureka Bollepalli 6, Yan Su 7, Doreen Chan 8, Erik J Tillman 8, Ali Moulton 8, Brittany de Temple 8, Arian Zari 8, Reshma Shringarpure 9, Timothy Rolph 8, Andrew Cheng 8, Kitty Yale 8
|
|
| |
|
|
| |
|
|
| |
| 137. | Development of Cilofexor, an intestinally-biased Farnesoid X Receptor agonist, for the treatment of fatty liver disease |
| |
J Pharmacol Exp Ther. 2024 Feb 26:JPET-AR-2023001900. doi:10.1124/jpet.123.001900.Online ahead of print.
David Hollenback 1, Eva Hambruch 2, Gero Fink 2, Manfred Birkel 2, Andreas Schulz 2, Martin Hornberger 2, Kathy Liu 3, Kelly MacLennan Staiger 4, Helen Desiree Krol 2, Ulrich Deuschle 2, Christoph Steeneck 2, Olaf Kinzel 2, John T Liles 3, Grant Budas 3, William J Watkins 3, Claus Kremoser 5
|
|
| |
|
|
| |
|
|
| |
| 140. | Global prevalence of MAFLD-related hepatocellular carcinoma: A systematic review and meta-analysis |
| |
Clin Mol Hepatol. 2024 Apr 16. doi: 10.3350/cmh.2024.0109. Online ahead of print.
Harry Crane 1, Guy D Eslick 2, Cameron Gofton 1 3, Anjiya Shaikh 4, George Cholankeril 5, Mark Cheah 6, Jian-Hong Zhong 7, Gianluca Svegliati-Baroni 8, Alessandro Vitale 9, Beom Kyung Kim 10, Sang Hoon Ahn 10, Mi Na Kim 10, Simone Strasser 11, Jacob George 1
|
|
| |
|
|
| |
|
|
| |
| 143. | The effects of food insecurity on hepatic steatosis and fibrosis in people with HIV |
| |
ClinGastroenterolHepatol. 2024Apr5:S15423565(24)002994.doi:10.1016/j.cgh.2024.03.017. Online ahead of print.
Ani Kardashian 1, Audrey Lloyd 2, Eduardo Vilar-Gomez 3, Susanna Naggie 4, Mark S Sulkowski 5, Tinsay Woreta 5, Jordan E Lake 6, Holly Crandall 3, Rohit Loomba 7, Laura A Wilson 8, Richard K Sterling 9, Sonya Heath 10, Samer Gawrieh 11, Naga P Chalasani 11, Jennifer C Price 12; HIV NASH Clinical Research Network
|
|
| |
|
|
| |
| 145. | Evolution of liver fibrosis in diabetic patients with NAFLD in a follow-up study: Hepatoprotective effects of sodium-glucose co-transporter-2 inhibitors |
| |
Dig Liver Dis. 2024 Apr;56(4):551-558. doi: 10.1016/j.dld.2023.09.023. Epub 2023 Oct 14.
Rosa Lombardi 1, Alessandro Mantovani 2, Annalisa Cespiati 3, Paolo Francione 4, Gabriele Maffi 3, Elena Del Zanna 3, Claudio Maffeis 5, Antonio Colecchia 6, Nicola Passigato 7, Alberto Ferrarese 7, Caterina Daniela Cusumanu 7, Rosanna Villani 8, Emanuela Orsi 9, Valeria Grancini 9, Lorena Airaghi 10, Daniela Bignamini 10, Gaetano Serviddio 8, Giovanni Targher 11, Paola Dongiovanni 10, Silvia Fargion 12, Anna Ludovica Fracanzani 3
|
|
| |
| 146. | Paediatric steatotic liver disease has unique characteristics: A multisociety statement endorsing the new nomenclature |
| |
J Pediatr Gastroenterol Nutr. 2024 Mar 26. doi: 10.1002/jpn3.12156. Online ahead of print.
European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN); Pietro Vajro; European Association for the Study of the Liver (EASL); North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN); Latin-American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (LASPGHAN); Asian Pan-Pacific Society for Pediatric Gastroenterology, Hepatology and Nutrition (APPSPGHAN); Pan Arab Society for Pediatric Gastroenterology and Nutrition (PASPGHAN); Commonwealth Association of Paediatric Gastroenterology & Nutrition (CAPGAN); Federation of International Societies of Pediatric Hepatology, Gastroenterology and Nutrition (FISPGHAN)
Collaborators
Ulrich Baumann, Bart G P Koot, Emer Fitzpatrick, Jake Mann, Pietro Vajro, Aleksander Krag, Debbie Shawcross, Sven Francque, Tobias Böttler, Benjamin D Gold, Jenifer R Lightdale, Marialena Mouzaki, Norberto Rodriguez-Baez, Rohit Kohli, Vicky L Ng, Daniel D'Agostino, Gilda Porta, José Spolidoro, Miguel Klünder-Klünder, Rodrigo Vázquez-Frias, Anupam Sibal, Jae Sung Ko, Kyung Mo Kim, Suporn Treepongkaruna, Yen-Hsuan Ni, Mohamed El-Guindi, Neelam Mohan, Elvira Verduci, Iqbal Memon, Mahmoud Bozo, Marcela Godoy, Marina Orsi, Marion Aw, Robert Bandsma, Samar Ibrahim, Stavra Xanthakos, Suporn Treepongkaruna, Tania Mitsinikos
|
|
| |
|
|
| |
| 148. | Accuracy, Reliability, and Comprehensibility of ChatGPT-Generated Medical Responses for Patients With Nonalcoholic Fatty Liver Disease |
| |
Clin Gastroenterol Hepatol. 2024 Apr;22(4):886-889.e5. doi: 10.1016/j.cgh.2023.08.033.Epub 2023 Sep 15.
Nicola Pugliese 1, Vincent Wai-Sun Wong 2, Jörn M Schattenberg 3, Manuel Romero-Gomez 4, Giada Sebastiani 5; NAFLD Expert Chatbot Working Group; Alessio Aghemo 14
Collaborators
NAFLD Expert Chatbot Working Group:
Laurent Castera 6, Cesare Hassan 7, Pinelopi Manousou 8, Luca Miele 9, Raquel Peck 10, Salvatore Petta 11, Luca Valenti 12, Zobair M Younossi 13
|
|
| |
|
|
| |
| 150. | No correlation between MASLD and poor outcome of Atezolizumab-Bevacizumab therapy in patients with advanced HCC |
| |
Liver Int. 2024 Apr;44(4):931-943. doi: 10.1111/liv.15833. Epub 2024 Jan 30.
Francisca-Dora Copil 1, Claudia Campani 2, Marie Lequoy 3, Philippe Sultanik 1, Lorraine Blaise 4, Mathilde Wagner 5, Nathalie Ganne-Carrié 2 4, Violaine Ozenne 3, Dominique Thabut 1 6, Jean-Charles Nault 2 4, Vlad Ratziu 1 6, Manon Allaire 1 2 7
|
|
| |
|
|
| |
|
| | | | | |
